Page 234 - Read Online

Singh et al. Myocardial protection in cardiac transplantation

Merlanti B, Frigerio M, Martinelli L. Does the cardioplegic solution times. Transplantation 2009;87:243-8.
have an effect on early outcomes following heart transplantation? Eur 70. Hassanein WH, Zellos L, Tyrrell TA, Healey NA, Crittenden MD,
J Cardiothorac Surg 2012;41:e48-52; discussion e52-3. Birjiniuk V, Khuri SF. Continuous perfusion of donor hearts in the
53. George TJ, Arnaoutakis GJ, Beaty CA, Shah AS, Conte JV, Halushka beating state extends preservation time and improves recovery of
MK. A novel method of measuring cardiac preservation injury function. J Thorac Cardiovasc Surg 1998;116:821-30.
demonstrates University of Wisconsin solution is associated with 71. Messer S, Ardehali A, Tsui S. Normothermic donor heart perfusion:
less ischaemic necrosis than Celsior in early cardiac allograft biopsy current clinical experience and the future. Transpl Int 2015;28:634-42.
specimens. J Heart Lung Transplant 2012;31:410-8. 72. Tenderich G, El-Banayosy A, Rosengard B, Tsui S, Wallwork J,
54. George TJ, Arnaoutakis GJ, Baumgartner WA, Shah AS, Conte JV. Hetzer R, Koerfer R, Hassanein W. 10: Prospective multi-center
Organ storage with University of Wisconsin solution is associated European trial to evaluate the safety and performance of the Organ
with improved outcomes after orthotopic heart transplantation. J Care System for heart transplants (PROTECT). Available from: http://
Heart Lung Transplant 2011;30:1033-43. www.jhltonline.org/article/S1053-2498(06)00824-2/fulltext. [Last
55. Kofler S, Bigdeli AK, Kaczmarek I, Kellerer D, Müller T, Schmoeckel accessed on 20 Oct 2017]
M, Steinbeck G, Uberfuhr P, Reichart B, Meiser B. Long-term 73. McCurry K, Jeevanandam V, Mihaljevic T, Couper G, Elanwar
outcomes after 1000 heart transplantations in six different eras of M, Saleh H, Ardehali A. 294: Prospective Multi-center safety and
innovation in a single center. Transpl Int 2009;22:1140-50. effectiveness evaluation of the Organ Care System device for cardiac
56. Garlicki M, Kołcz J, Rudziński P, Kapelak B, Sadowski J, Wójcik use (PROCEED). Available from: http://www.jhltonline.org/article/
S, Pietrzyk E, Frasik W, Drukała J, Dziatkowiak A. Myocardial S1053-2498(07)01142-4/abstract. [Last accessed on 20 Oct 2017]
protection for transplantation. Transplant Proc 1999;31:2079-83. 74. Hamed A, Tsui S, Huber J, Lin R, Poggio EC, Ardehali A. 19: Serum
57. Lee S, Huang CS, Kawamura T, Shigemura N, Billiar TR, Nakao lactate is a highly sensitive and specific predictor of post cardiac
A, Toyoda Y. Histidine-tryptophan-ketoglutarate or celsior: which transplant outcomes using the Organ Care System. J Heart Lung
is more suitable for cold preservation for cardiac grafts from older Transplant 2009;28:S71.
donors? Ann Thorac Surg 2011;91:755-63. 75. Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka
58. Ackemann J, Gross W, Mory M, Schaefer M, Gebhard MM. Celsior Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R,
versus custodiol: early postischemic recovery after cardioplegia and Kobashigawa J; PROCEED II trial investigators. Ex-vivo perfusion
ischemia at 5 degrees C. Ann Thorac Surg 2002;74:522-9. of donor hearts for human heart transplantation (PROCEED II): a
59. Lurati Buse GA, Koller MT, Grapow M, Bolliger D, Seeberger M, prospective, open-label, multicentre, randomised non-inferiority trial.
Filipovic M. The prognostic value of troponin release after adult cardiac Lancet 2015;385:2577-84.
surgery - a meta-analysis. Eur J Cardiothorac Surg 2010;37:399-406. 76. Daemen JW, Kootstra G, Wijnen RM, Yin M, Heineman E. Nonheart-
60. De Santo LS, Torella M, Romano G, Maiello C, Buonocore beating donors: the Maastricht experience. Clin Transpl 1994:303-16.
M, Bancone C, Della Corte A, Galdieri N, Nappi G, Amarelli 77. Iyer A, Gao L, Doyle A, Rao P, Cropper JR, Soto C, Dinale A,
C. Perioperative myocardial injury after adult heart transplant: Kumarasinghe G, Jabbour A, Hicks M, Jansz PC, Feneley MP,
determinants and prognostic value. PLoS One 2015;10:e0120813. Harvey RP, Graham RM, Dhital KK, MacDonald PS. Normothermic
61. Gross GJ, Kersten JR, Warltier DC. Mechanisms of postischemic ex vivo perfusion provides superior organ preservation and enables
contractile dysfunction. Ann Thorac Surg 1999;68:1898-904. viability assessment of hearts from DCD donors. Am J Transplant
62. Dengler TJ, Gleissner CA, Klingenberg R, Sack FU, Schnabel PA, 2015;15:371-80.
Katus HA. Biomarkers after heart transplantation: nongenomic. Heart 78. Dhital KK, Iyer A, Connellan M, Chew HC, Gao L, Doyle A, Hicks
Fail Clin 2007;3:69-81. M, Kumarasinghe G, Soto C, Dinale A, Cartwright B, Nair P, Granger
63. Masuda M, Morita S, Tomita H, Kurisu K, Nishida T, Tominaga R, E, Jansz P, Jabbour A, Kotlyar E, Keogh A, Hayward C, Graham
Yasui H. Off-pump CABG attenuates myocardial enzyme leakage R, Spratt P, Macdonald P. Adult heart transplantation with distant
but not postoperative brain natriuretic peptide secretion. Ann Thorac procurement and ex-vivo preservation of donor hearts after circulatory
Cardiovasc Surg 2002;8:139-44. death: a case series. Lancet 2015;385:2585-91.
64. Hajjar L, Galas F, Grande S, Campos M, Silva R, Marques A, 79. Boucek MM, Mashburn C, Dunn SM, Frizell R, Edwards L, Pietra
Leao W, Auler Jr J. Plasma brain natriuretic peptide and cardiac B, Campbell D; Denver Children’s Pediatric Heart Transplant Team.
troponin I concentrations after adult cardiac surgery: association with Pediatric heart transplantation after declaration of cardiocirculatory
cardiovascular death, postoperative cardiac, renal and pulmonary death. N Engl J Med 2008;359:709-14.
dysfunction. Available from: https://ccforum.biomedcentral.com/ 80. Walsh F. Europe’s first non-beating heart transplant. Available from:
track/pdf/10.1186/cc6665. [Last accessed on 20 Oct 2017] http://www.bbc.com/news/health-32056350. [Last accessed on 20
65. McIlroy DR, Wallace S, Roubos N. Brain natriuretic peptide (BNP) Oct 2017]
as a biomarker of myocardial ischemia-reperfusion injury in cardiac 81. Truog RD, Miller FG, Halpern SD. The dead-donor rule and the future
transplantation. J Cardiothorac Vasc Anesth 2010;24:939-45. of organ donation. N Engl J Med 2013;369:1287-9.
66. Cavarretta E, Frati G. MicroRNAs in coronary heart disease: ready to 82. Ullah S, Zabala L, Watkins B, Schmitz ML. Cardiac organ donor
enter the clinical arena? Biomed Res Int 2016;2016:2150763. management. Perfusion 2006;21:93-8.
67. Wang E, Nie Y, Zhao Q, Wang W, Huang J, Liao Z, Zhang H, Hu 83. Cuisinier A, Maufrais C, Payen JF, Nottin S, Walther G, Bouzat P.
S, Zheng Z. Circulating miRNAs reflect early myocardial injury and Myocardial function at the early phase of traumatic brain injury: a
recovery after heart transplantation. J Cardiothorac Surg 2013;8:165. prospective controlled study. Scand J Trauma Resusc Emerg Med
68. Russo MJ, Chen JM, Sorabella RA, Martens TP, Garrido M, Davies 2016;24:129.
RR, George I, Cheema FH, Mosca RS, Mital S, Ascheim DD, 84. Novitzky D, Rhodin J, Cooper DK, Ye Y, Min KW, DeBault L.
Argenziano M, Stewart AS, Oz MC, Naka Y. The effect of ischaemic Ultrastructure changes associated with brain death in the human donor
time on survival after heart transplantation varies by donor age: an heart. Transpl Int 1997;10:24-32.
analysis of the United Network for organ sharing database. J Thorac 85. Kilic A, Emani S, Sai-Sudhakar CB, Higgins RS, Whitson BA. Donor
Cardiovasc Surg 2007;133:554-9. selection in heart transplantation. J Thorac Dis 2014;6:1097-104.
69. Goldsmith KA, Demiris N, Gooi JH, Sharples LD, Jenkins DP, Dhital 86. Lee H, Cho YH, Sung K, Yang JH, Chung CR, Jeon K, Suh GY. The
KK, Tsui SS. Life-years gained by reducing donor heart ischaemic use of extracorporeal circulation in suspected brain dead organ donors

Vessel Plus ¦ Volume 1 ¦ December 28, 2017 227